Congenital Diaphragmatic Hernia
Rare Disease·MeSH: Hernias, Diaphragmatic, Congenital
Prevalence
30.0 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| milrinone | GH Research PLC (GHRS) |
Frequently asked questions
How many drugs are in development for Congenital Diaphragmatic Hernia?
BioSniper tracks 1 drug in development for Congenital Diaphragmatic Hernia across 1 company.
How many clinical trials target Congenital Diaphragmatic Hernia?
There are 3 clinical trials targeting Congenital Diaphragmatic Hernia tracked by BioSniper.
What is the prevalence of Congenital Diaphragmatic Hernia?
The estimated prevalence of Congenital Diaphragmatic Hernia is approximately 30.0 per 100,000 population.
Deep-dive into Congenital Diaphragmatic Hernia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis